Analyst Ratings For NASDAQ:LOXO – Loxo Oncology (NASDAQ:LOXO)
Today, JMP Securities reiterated its Outperform rating on NASDAQ:LOXO – Loxo Oncology (NASDAQ:LOXO) with a price target of $95.00 ➝ $152.00.
Some recent analyst ratings include
- 5/9/2018-JMP Securities Reiterated Rating of Outperform.
- 4/16/2018-Morgan Stanley Upgrade from a “Equal Weight ➝ Overweight” rating to a “” rating.
- 4/16/2018-William Blair Reiterated Rating of Buy.
- 3/5/2018-Citigroup Reiterated Rating of Buy ➝ Buy.
- 3/1/2018-Cann Reiterated Rating of Buy.
- 2/22/2018-CIBC initiated coverage with a Outperform ➝ Outperform rating.
- On 4/25/2018 Joshua H Bilenker, CEO, sold 15,000 with an average share price of $131.12 per share and the total transaction amounting to $1,966,800.00.
- On 4/25/2018 Naarden Jacob Van, Insider, sold 3,082 with an average share price of $131.23 per share and the total transaction amounting to $404,450.86.
- On 4/24/2018 Jennifer Burstein, VP, sold 1,700 with an average share price of $131.65 per share and the total transaction amounting to $223,805.00.
- On 4/20/2018 Lori Anne Kunkel, Director, sold 5,000 with an average share price of $132.68 per share and the total transaction amounting to $663,400.00.
- On 3/14/2018 Joshua H Bilenker, CEO, sold 15,000 with an average share price of $131.54 per share and the total transaction amounting to $1,973,100.00.
- On 3/14/2018 Naarden Jacob Van, Insider, sold 3,082 with an average share price of $131.41 per share and the total transaction amounting to $405,005.62.
- On 3/13/2018 Jennifer Burstein, VP, sold 1,700 with an average share price of $131.33 per share and the total transaction amounting to $223,261.00.
Recent Trading Activity for NASDAQ:LOXO – Loxo Oncology (NASDAQ:LOXO)
Shares of NASDAQ:LOXO – Loxo Oncology closed the previous trading session at 125.18 up +1.01 0.81% with 128.52459716796875 shares trading hands.